Literature DB >> 2041779

High level heterologous expression in E. coli using mutant forms of the lac promoter.

A J Makoff1, M D Oxer.   

Abstract

Single base deletions in the lac promoter which reduced the 18bp spacing between the -35 and -10 homology regions to 17bp, increased the strength of the promoter. A single base substitution (T----G) in the -35 region to generate the consensus sequence TTG-ACA increased the strength further and no longer required a 17bp spacing. The mutated lac promoter was as powerful as a shorter form of the tac promoter which lacked two AT-rich regions upstream of the -35 region, and expressed the P69 surface antigen (pertactin) of Bordetella pertussis to 30-40% total cell protein and tetanus toxin fragment C to 16-20% total cell protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041779      PMCID: PMC329451          DOI: 10.1093/nar/19.9.2417

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  Promoter selectivity of Escherichia coli RNA polymerase: effect of base substitutions in the promoter -35 region on promoter strength.

Authors:  M Kobayashi; K Nagata; A Ishihama
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

Review 2.  Regulatory sequences involved in the promotion and termination of RNA transcription.

Authors:  M Rosenberg; D Court
Journal:  Annu Rev Genet       Date:  1979       Impact factor: 16.830

3.  Translational fusions with fragments of the trpE gene improve the expression of a poorly expressed heterologous gene in Escherichia coli.

Authors:  A Makoff; N Parry; L Dicken
Journal:  J Gen Microbiol       Date:  1989-01

4.  The use of two-cistron constructions in improving the expression of a heterologous gene in E. coli.

Authors:  A J Makoff; A E Smallwood
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

5.  DNA restriction enzyme from E. coli.

Authors:  M Meselson; R Yuan
Journal:  Nature       Date:  1968-03-23       Impact factor: 49.962

6.  Spacer mutations in the lac ps promoter.

Authors:  J E Stefano; J D Gralla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

Review 7.  E. coli RNA polymerase interacts homologously with two different promoters.

Authors:  U Siebenlist; R B Simpson; W Gilbert
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

8.  Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons.

Authors:  A J Makoff; M D Oxer; M A Romanos; N F Fairweather; S Ballantine
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

9.  Protective surface antigen P69 of Bordetella pertussis: its characterization and very high level expression in Escherichia coli.

Authors:  A J Makoff; M D Oxer; S P Ballantine; N F Fairweather; I G Charles
Journal:  Biotechnology (N Y)       Date:  1990-11

10.  Functional dissection of Escherichia coli promoters: information in the transcribed region is involved in late steps of the overall process.

Authors:  W Kammerer; U Deuschle; R Gentz; H Bujard
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  5 in total

Review 1.  Recombinant protein expression in Escherichia coli: advances and challenges.

Authors:  Germán L Rosano; Eduardo A Ceccarelli
Journal:  Front Microbiol       Date:  2014-04-17       Impact factor: 5.640

2.  Comparison of E. coli based self-inducible expression systems containing different human heat shock proteins.

Authors:  Fatemeh Sadat Shariati; Malihe Keramati; Vahideh Valizadeh; Reza Ahangari Cohan; Dariush Norouzian
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

3.  Transcription initiation by mix and match elements: flexibility for polymerase binding to bacterial promoters.

Authors:  India G Hook-Barnard; Deborah M Hinton
Journal:  Gene Regul Syst Bio       Date:  2007

Review 4.  Synthetic promoter design for new microbial chassis.

Authors:  James Gilman; John Love
Journal:  Biochem Soc Trans       Date:  2016-06-15       Impact factor: 5.407

5.  Safety and Immunogenicity of a Recombinant Tetanus Vaccine in Healthy Adults in China: A Randomized, Double-Blind, Dose Escalation, Placebo- and Positive-Controlled, Phase 1/2 Trial.

Authors:  Xiaowei Xu; Rui Yu; Lanlan Xiao; Jie Wang; Meihong Yu; Junjie Xu; Yajun Tan; Xiao Ma; Xiaoxin Wu; Jiangshan Lian; Kaizhou Huang; Xiaoxi Ouyang; Sheng Bi; Shipo Wu; Xiaoyan Wang; Jiandi Jin; Ling Yu; Huafen Zhang; Qi Wei; Jinfa Shi; Wei Chen; Lanjuan Li
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.